Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Tweet
Share
E-mailGet Alerts RNTX Hot Sheet
Join SI Premium – FREE
Rein Therapeutics Inc. (NASDAQ: RNTX) reported Q2 EPS of ($0.10), $0.39 better than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Rein Therapeutics Inc. (RNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fox upgraded to overweight as Roku deal, ad strength lift outlook
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- MicroVision prices $17 million public offering at $2.50 per unit
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
